scholarly journals Radiofrequency wire recanalization of upper vs. lower central venous occlusions: technical success and strategies

2017 ◽  
Vol 28 (2) ◽  
pp. S138
Author(s):  
S Gupta ◽  
S Desai ◽  
K Sato ◽  
R Vogelzang ◽  
S Resnick
2021 ◽  
pp. 112972982110480
Author(s):  
Brendan C Cline ◽  
Adam Zuchowski ◽  
Shawn M Gage ◽  
Jonathan G Martin ◽  
James Ronald ◽  
...  

Background: The purpose of this study was to assess the feasibility and outcomes of recanalization and subsequent HeRO graft outflow component insertion across stent interstices in patients with an otherwise abandoned upper extremity. Methods: Over a 10-year period, 15 patients underwent central venous recanalization by interventional radiology across the interstices of one or more occluded stents for the purpose of subsequent HeRO graft creation. A tunneled central venous catheter was left across the stent and occlusions with tip in right atrium. On a later date, the catheter was used for rapid guidewire access for HeRO graft implantation in the OR by vascular surgery. Procedural and clinical outcomes were determined by retrospective review. Primary and secondary HeRO graft patency rates were estimated with the Kaplan-Meier technique. Results: The technical success rates of recanalization across stent interstices was 100% (15/15). Between one and four overlapping stent walls were traversed. The technical success of the patients who underwent attempted HeRO graft implantation with outflow component traversing across stent interstices was 91% (11/12). No major complications were encountered with either recanalization or HeRO graft implantation. The primary and secondary HeRO patency rates at 12 months were 64% and 80%, respectively. Conclusion: HeRO graft insertion across stent interstices is feasible and can provide effective permanent AV access; thus, the presence of stents across the subclavian and brachiocephalic veins should not be considered a contraindication.


2015 ◽  
Vol 16 (4) ◽  
pp. 309-314 ◽  
Author(s):  
Gajan Sivananthan ◽  
Daniel H. MacArthur ◽  
Kevin P. Daly ◽  
David W. Allen ◽  
Salar Hakham ◽  
...  

2020 ◽  
Vol 49 (6) ◽  
pp. 360-366
Author(s):  
Hui Lin Wong ◽  
Shaun Xavier JM Chan ◽  
Satheesh Ramamuthy ◽  
Kiang Hong Tay ◽  
Tze Tec Chong ◽  
...  

Introduction: To evaluate the mid-term outcomes of regular surveillance venography with or without percutaneous transluminal angioplasty in haemodialysis patients presenting with central venous occlusive disease. Materials and Methods: A single-centre retrospective analysis of haemodialysis patients who presented with central vein occlusion (CVO) and central vein stenosis (CVS) between January 2008 and December 2011 was performed. CVO and significant CVS were defined as 100% and >50% luminal narrowing respectively. Upon successful angioplasty on first presentation, patients were followed up with regular surveillance venography within 3–6 months of the intervention and were re-treated when a significant stenosis or occlusion was demonstrated. Data on patient’s demographics, comorbidities, presenting symptoms, type of upper limb dialysis access, lesion characteristics and complications were collected. Technical success, primary patency and primary assisted patency were analysed. Results: Thirty-five patients with CVO and 77 patients with CVS were enrolled. The technical success of initial PTA was 77% and 73% for the CVO and CVS groups, respectively. The primary patency at 3 months was 65% and 55% for the CVO group and CVS group, respectively (P = 0.32). The primary assisted patency at 1 year was 88% and 99% for the CVO group and CVS group, respectively (P = 0.009). At 2 years, the primary assisted patency were 77% and 90%, respectively (P = 0.07). There was significant difference in the overall primary assisted patency (P = 0.048) between the CVO and CVS groups. Conclusion: CVOs are more difficult to treat than CVS. High primary assisted patency rates can be achieved with surveillance venography, albeit at the expense of increased number of interventions. Further cost effectiveness studies need to be performed to study the true benefit of our surveillance programme. Ann Acad Med Singapore 2020;49:360–66 Key words: Dialysis circuit, End stage renal failure, Renal replacement therapy


2014 ◽  
Vol 25 (3) ◽  
pp. S16 ◽  
Author(s):  
G. Sivananthan ◽  
D. MacArthur ◽  
S. Hakham ◽  
R. Marcus ◽  
K.P. Daly ◽  
...  

2021 ◽  
pp. 112972982110343
Author(s):  
Romman Nourzaie ◽  
Hiba Abbas ◽  
Aneeta Parthipun ◽  
Soo Boolkah ◽  
Irfan Ahmed ◽  
...  

Purpose: The aim was to determine the success, safety and post procedure complications of peripherally inserted central catheters as centrally inserted central catheters (CICC). Materials and method: One hundred and sixty-one consecutive infants and neonates, who underwent image guided tunnelled central venous catheter insertion were retrospectively evaluated between April 2008 and April 2018. Patient’s demographics, site of access and procedure details were recorded. Outcomes included technical success and post procedure complications. Results: One hundred and eighty-two CICCs were inserted in 161 patients (49.7%, n = 80 male). Mean patient age was 100 days (range: 0–342) with a mean weight of 4.20 kg (range 1.80–9.40). The most common indication was for antibiotics administration (41%; n = 66). Technical success was 99% (181/182). Early complications (<7 days) were seen in 8.8% ( n = 13). This included inadvertent line removal in 5.5%, catheter-related bloodstream infection in 1.1% and catheter occlusion in 2.2% ( n = 4). Average line functional duration prior to removal was 26 days (range 0–180). 77.5% of the lines lasted for the intended duration of treatment. In the neonate subgroup, 84.1% (37/44 lines) of lines remained in situ for the intended duration of treatment. Conclusion: Tunnelled central venous catheters using non-cuffed peripherally inserted central catheters in infants is a safe technique with excellent success rate and minimal complications rates.


2003 ◽  
Vol 44 (5) ◽  
pp. 508-516 ◽  
Author(s):  
K. Knutstad ◽  
B. Hager ◽  
M. Hauser

Central venous access is an important aspect of medical treatment. There are different designs of access devices for different purposes. In essence, they can be classified as short- and long-term devices. Insertion procedures vary for different devices. There is a risk for both acute and delayed complications. Radiology plays a central role both in placement and in device management. Image-guided insertion increases technical success and reduces the rate of acute complications. The diagnostic approach to long-term complications includes radiography, fluoroscopy, CT, and ultrasound. Treatment by interventional procedures is possible for a number of these conditions. These interventions increase device lifespan and reduce the number of necessary reinsertions.


Sign in / Sign up

Export Citation Format

Share Document